Noticias y Actividades de Foresight Diagnostics

Foresight Diagnostics pertenece a Quest Diagnostics.

Quest Diagnostics es una de las ...

• Forbes Global 2000 (#1096);
• Fortune 500 (#423);
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

Quest Diagnostics es una empresa que cotiza bajo el símbolo de cotización DGX (US).

Quest Diagnostics tiene presencia directa en 4 países.

Quest Diagnostics posee 6 subsidiarias incluyendo Centogene, Foresight Diagnostics y Haystack Oncology.

Ellos se encuentran en:

• Biotecnología57%
• Salud43%

Fusión, adquisición y financiación con participación de Quest Diagnostics.

• Natera has announced the acquisition of Foresight Diagnostics  (publicado el 5 de diciembre de 2025).

Ver el organigrama con sus 13 ejecutivos principales

Biografías más buscadas en Foresight Diagnostics

• Jake Chabon, Chief Executive Officer and Chief Scientific Officer
• Maximilian Diehn, Board Member
• Sandra Close, Chief Operating Officer and Chief Compliance Officer

Recientes movimientos de ejecutivos en Foresight Diagnostics

• Mckenzie Carlisle que ha sido Senior Director, Regulatory Operations & Compliance, pasa a ser Senior Director, Regulatory Affairs & Quality Assurance  (noticia publicada el 10 de marzo de 2026).

Recientes movimientos de ejecutivos en Quest Diagnostics

• Timothy Wentworth, se ha incorporado a la empresa como Director  (noticia publicada el 13 de marzo de 2026).
• Benjamin Beauvalot, se ha incorporado a la empresa como Senior Vice President, Chief Strategy and Mergers and Acquisitions Officer  (noticia publicada el 26 de febrero de 2026).

Crear su alerta
para seguir los movimientos de los ejecutivos en Foresight Diagnostics.

Quest Diagnostics tiene 2.405 competidores entre los que se incluyen Eurofins (Luxemburgo), Lonza (Suiza) y BioNTech (Alemania).

Popular M&A news in Biotecnología

• IMU Biosciences acaba de anunciar una recaudación de fondos de 53 millones de dólares. (publicado el 3 de junio de 2026).
• NewLimit acaba de anunciar una recaudación de fondos de 435 millones de dólares. (publicado el 3 de junio de 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (publicado el 1 de junio de 2026)..

Otros contactos sugeridos en el sector Biotecnología

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer en Inceptive
• Jan Van de Winkel - President and Chief Executive Officer en Genmab
• Valerie Hanote - Non-Executive Director en Eurofins

Saber más sobre el sector Biotecnología

Últimos comunicados de prensa de Foresight Diagnostics

• Natera Acquires Foresight Diagnostics | foresight-dx.com
• Foresight Diagnostics Announces Multiple Presentations in Lymphoma Featuring PhasED-Seq™ Ultrasensitive MRD Analysis at the upcoming ASH Annual Meeting | foresight-dx.com
• Foresight Diagnostics to Present Clinical Performance Data on Foresight CLARITY™ MRD at IASLC 2025 World Conference on Lung Cancer | foresight-dx.com
• Foresight Diagnostics and Roche Enter Licensing Agreement for PhasED-Seq™ Technology in Non-Hodgkin's Lymphoma | foresight-dx.com
• Foresight Diagnostics Announces Publication of Landmark Study Demonstrating Prognostic Value of Ultrasensitive ctDNA-MRD Detection in Large B-Cell Lymphoma | foresight-dx.com
• Foresight Diagnostics and Partners to Present Independent Validation Data for its CLARITY™ MRD Assay at the 2025 European Hematology Association (EHA) Congress and International Conference on Malignant Lymphoma (ICML) | foresight-dx.com
• Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma | foresight-dx.com
• Foresight Diagnostics Presents Independent Validation of its CLARITY Minimal Residual Disease Assay in Multi-center Study of Frontline DLBCL at the 2025 ASCO Annual Meeting | foresight-dx.com
• Foresight Diagnostics to Participate in the Jefferies Global Healthcare Conference | foresight-dx.com
• Foresight Diagnostics and Partners to Present New Data on Ultra-sensitive Minimal Residual Disease Detection and Clinical Trial Progress at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting | foresight-dx.com
• View more press releases Close

Redes sociales sobre Foresight Diagnostics

• Foresight Diagnostics en Wikipedia, Google News y Yahoo Finance
• Foresight Diagnostics en LinkedIn, Twitter y YouTube